Successful treatment of status migrainosus after electroconvulsive therapy with dihydroergotamine.
We describe a case of status migrainosus precipitated by electroconvulsive therapy (ECT) that was refractory to treatment with triptan medications but which resolved with dihydroergotamine (DHE). We briefly review some of the receptor pharmacology possibly related to this observation.
Stead
Matt
M
Department of Neurology, Mayo Clinic, Rochester, MN 55905, USA.
Josephs
Keith A
KA
D004087:Dihydroergotamine / Q000627:therapeutic use*; D004565:Electroconvulsive Therapy / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008875:Middle Aged; D008881:Migraine Disorders / Q000188:drug therapy* / Q000209:etiology; D014662:Vasoconstrictor Agents / Q000627:therapeutic use*
D014662:Vasoconstrictor Agents; D004087:Dihydroergotamine